Related Experiment Video
Updated: Feb 8, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Author Correction: Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K Bommareddy1, Megha Shettigar2, Howard L Kaufman3,4
1Rutgers Graduate School of Biomedical Sciences, New Brunswick, NJ, USA.
Abstract:
In the initially published version of this article online in advance of print, a reference (Ajina, A. & Maher, J. Prospects for combined use of oncolytic viruses and CAR T-cells. J. Immunother. Cancer 5, 90 (2017)) was omitted in error from the following sentence: "The ability of oncolytic viruses to increase the expression of MHC class I molecules by cancer cells is also predicted to enhance ACT with TILs or TCR-engineered and chimeric antigen receptor (CAR) T cells that target tumour-specific antigens". This has been corrected in the HTML and PDF versions of the manuscript.
Related Concept Videos
Milgram's Obedience to Authority
Tumor Immunotherapy
Distance Corrections
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Power Factor Correction
What are Viruses?

